Cardiff Oncology, Inc. (CRDF) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 47.34M | 60.13M | 61.8M | 73.7M | 82.71M | 95.05M | 59.33M | 62.25M | 69.99M | 77.41M | 83.91M | 92.73M |
| Cash & Short-Term Investments | 46.06M | 58.3M | 60.59M | 70.96M | 79.89M | 91.75M | 57.67M | 60.32M | 67.19M | 74.82M | 81.36M | 89.43M |
| Cash Only | 8.54M | 17.47M | 10.13M | 10.78M | 24.09M | 51.47M | 13.04M | 25.5M | 18.66M | 21.66M | 15.23M | 19.37M |
| Short-Term Investments | 37.51M | 40.83M | 50.46M | 60.17M | 55.79M | 40.28M | 44.63M | 34.82M | 48.53M | 53.17M | 66.13M | 70.06M |
| Accounts Receivable | 191K | 182K | 254K | 526K | 405K | 773K | 618K | 451K | 393K | 288K | 198K | 161K |
| Days Sales Outstanding | 409.39 | 82.53 | 299 | 350.09 | 486.33 | 423.75 | 298.02 | 235.6 | 151.15 | 143.31 | 117.12 | 352.63 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.09M | 1.64M | 0 | 2.21M | 2.42M | 2.54M | 1.05M | 1.48M | 2.41M | 2.3M | 2.34M | 3.14M |
| Total Non-Current Assets | 1.83M | 1.76M | 1.98M | 2.04M | 2.1M | 2.14M | 3.56M | 3.81M | 4.05M | 4.22M | 4.55M | 4.72M |
| Property, Plant & Equipment | 986K | 1.21M | 1.43M | 1.64M | 1.84M | 2.07M | 2.3M | 2.53M | 2.77M | 2.95M | 3.16M | 3.33M |
| Fixed Asset Turnover | 0.04x | 0.18x | 0.08x | 0.07x | 0.06x | 0.07x | 0.07x | 0.06x | 0.07x | 0.05x | 0.04x | 0.03x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 844K | 549K | 549K | 401K | 257K | 69K | 1.27M | 1.27M | 1.27M | 1.28M | 1.39M | 1.39M |
| Total Assets | 49.17M | 61.88M | 63.78M | 75.74M | 84.81M | 97.19M | 62.9M | 66.05M | 74.04M | 81.64M | 88.45M | 97.45M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -42.02% | -36.33% | 1.41% | 14.67% | 14.55% | 19.05% | -28.89% | -32.22% | -30.51% | -29.74% | -28.45% | -25.75% |
| Total Current Liabilities | 14.46M | 16.39M | 14.71M | 16.67M | 13.29M | 13.43M | 12.53M | 12.52M | 11.84M | 10.44M | 9.02M | 9.12M |
| Accounts Payable | 5.48M | 8.09M | 2.44M | 6.01M | 3.63M | 4.82M | 4.64M | 5.11M | 5.19M | 1.97M | 2.18M | 2.94M |
| Days Payables Outstanding | 2.76K | - | - | 37.87 | - | - | 46.53 | 4.46K | 3.19K | 1.85K | 2.2K | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.34M | 7.58M | 0 | 2.25M | 1.3M | 2.75M | 0 | 4.92M | 1.23M | 2.74M | 2.46M | 2.17M |
| Current Ratio | 3.27x | 3.67x | 4.20x | 4.42x | 6.22x | 7.08x | 4.74x | 4.97x | 5.91x | 7.41x | 9.30x | 10.16x |
| Quick Ratio | 3.27x | 3.67x | 4.20x | 4.42x | 6.22x | 7.08x | 4.74x | 4.97x | 5.91x | 7.41x | 9.30x | 10.16x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 102K | 284K | 464K | 640K | 813K | 979K | 1.14M | 1.3M | 1.46M | 1.61M | 1.75M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 102K | 284K | 464K | 640K | 813K | 979K | 1.14M | 1.3M | 1.46M | 1.61M | 1.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 14.46M | 16.5M | 14.99M | 17.13M | 13.93M | 14.24M | 13.5M | 13.66M | 13.14M | 11.9M | 10.63M | 10.88M |
| Total Debt | 646K | 832K | 1.01M | 1.19M | 1.36M | 1.52M | 1.69M | 1.84M | 2M | 2.15M | 2.29M | 2.44M |
| Net Debt | -7.9M | -16.64M | -9.13M | -9.6M | -22.74M | -49.95M | -11.35M | -23.66M | -16.66M | -19.51M | -12.94M | -16.93M |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.03x | 0.04x | 0.03x | 0.03x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 34.71M | 45.39M | 48.79M | 58.61M | 70.88M | 82.95M | 49.39M | 52.39M | 60.89M | 69.74M | 77.83M | 86.58M |
| Equity Growth % | -51.03% | -45.28% | -1.22% | 11.87% | 16.39% | 18.94% | -36.54% | -39.49% | -36.9% | -34.42% | -31.26% | -28.13% |
| Book Value per Share | 0.51 | 0.68 | 0.73 | 0.88 | 1.49 | 1.74 | 1.05 | 1.17 | 1.36 | 1.56 | 1.74 | 1.94 |
| Total Shareholders' Equity | 34.71M | 45.39M | 48.79M | 58.61M | 70.88M | 82.95M | 49.39M | 52.39M | 60.89M | 69.74M | 77.83M | 86.58M |
| Common Stock | 7K | 7K | 7K | 7K | 7K | 7K | 5K | 5K | 4K | 4K | 4K | 4K |
| Retained Earnings | -442.38M | -430.03M | -422.81M | -411.56M | -397.61M | -384.18M | -372.39M | -360.54M | -348.76M | -339.54M | -330.2M | -320.47M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -49K | 50K | 50K | 17K | 27K | 34K | 82K | -97K | -132K | -67K | -407K | -431K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |